Yazan Daaboul

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine · 2016 · 1.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction

C. Michael Gibson, Serge Korjian, Pierluigi Tricoci et al. · Circulation · 2016 · 186 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

C. Michael Gibson, Robert P. Giugliano, Robert A. Kloner et al. · European Heart Journal · 2015 · 155 citations · Full text

Medicine, Cardiology, Pharmacology +17

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification

C. Michael Gibson, Alex C. Spyropoulos, Alexander Cohen et al. · TH Open · 2017 · 139 citations · Full text

Medicine, Internal Medicine, Clinical Decision Support +16

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

C. Michael Gibson, Duane S. Pinto, Gerald Chi et al. · Circulation · 2016 · 95 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17